메뉴 건너뛰기




Volumn 66, Issue , 2012, Pages 287-294

Potential therapeutic interventions via EP2/EP4 prostaglandin receptors

Author keywords

EP4; Immune response; Inflammation; PGE2

Indexed keywords


EID: 84867948487     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.998859     Document Type: Review
Times cited : (4)

References (79)
  • 1
    • 3042700885 scopus 로고    scopus 로고
    • Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production
    • Akaogi J., Yamada H., Kuroda Y., Nacionales D. C., Reeves W. H., Satoh M.: Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production. J. Leukoc. Biol., 2004;76:227-236
    • (2004) J. Leukoc. Biol. , vol.76 , pp. 227-236
    • Akaogi, J.1    Yamada, H.2    Kuroda, Y.3    Nacionales, D.C.4    Reeves, W.H.5    Satoh, M.6
  • 2
    • 80054022565 scopus 로고    scopus 로고
    • The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache
    • Antonova M., Wienecke T., Maubach K., Thomas E., Olesen J., Ashina M.: The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache. J. Headache Pain, 2011;12:551-559
    • (2011) J. Headache Pain , vol.12 , pp. 551-559
    • Antonova, M.1    Wienecke, T.2    Maubach, K.3    Thomas, E.4    Olesen, J.5    Ashina, M.6
  • 3
    • 33744831158 scopus 로고    scopus 로고
    • Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor
    • Aoudjit L., Potapov A., Takano T.: Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. Am. J. Physiol. Renal Physiol., 2006;290:F1534-F1542
    • (2006) Am. J. Physiol. Renal Physiol. , vol.290
    • Aoudjit, L.1    Potapov, A.2    Takano, T.3
  • 4
    • 0029832749 scopus 로고    scopus 로고
    • Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia
    • Bandeira-Melo C., Singh Y., Cordeiro R. S., e Silva P. M., Martins M. A.: Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia. Br. J. Pharmacol., 1996;118:2192-2198
    • (1996) Br. J. Pharmacol. , vol.118 , pp. 2192-2198
    • Bandeira-Melo, C.1    Singh, Y.2    Cordeiro, R.S.3    Silva, P.M.4    Martins, M.A.5
  • 9
    • 0028183018 scopus 로고
    • International Union of Pharmacology classfication of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
    • Coleman R. A., Smith W. L., Narumiya S.: International Union of Pharmacology classfication of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 1994;46:205-229
    • (1994) Pharmacol. Rev. , vol.46 , pp. 205-229
    • Coleman, R.A.1    Smith, W.L.2    Narumiya, S.3
  • 12
    • 0442276338 scopus 로고    scopus 로고
    • Pharmacogenomics of immunosuppressive drug metabolism
    • Fredericks S., Holt D. W.: Pharmacogenomics of immunosuppressive drug metabolism. Curr. Opin. Nephrol. Hypertens., 2003;12:607-613
    • (2003) Curr. Opin. Nephrol. Hypertens. , vol.12 , pp. 607-613
    • Fredericks, S.1    Holt, D.W.2
  • 14
    • 0032903965 scopus 로고    scopus 로고
    • Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation
    • Gauvreau G. M., Watson R. M., O'Byrne P. M.: Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med., 1999;159:31-36
    • (1999) Am. J. Respir. Crit. Care Med. , vol.159 , pp. 31-36
    • Gauvreau, G.M.1    Watson, R.M.2    O'Byrne, P.M.3
  • 16
    • 0032034245 scopus 로고    scopus 로고
    • PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells
    • Gurlo T., Huang W. W., von Grafenstein H.: PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells. Cytokine, 1998;10:265-274
    • (1998) Cytokine , vol.10 , pp. 265-274
    • Gurlo, T.1    Huang, W.W.2    Von Grafenstein, H.3
  • 17
    • 0037666202 scopus 로고    scopus 로고
    • Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes
    • Harizi H., Grosset C., Gualde N.: Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J. Leukoc. Biol., 2003;73:756-763
    • (2003) J. Leukoc. Biol. , vol.73 , pp. 756-763
    • Harizi, H.1    Grosset, C.2    Gualde, N.3
  • 18
    • 38949099298 scopus 로고    scopus 로고
    • EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells
    • Hattori R., Shimizu S., Majima Y., Shimizu T.: EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells. Ann. Otol. Rhinol. Laryngol., 2008;117:51-58
    • (2008) Ann. Otol. Rhinol. Laryngol. , vol.117 , pp. 51-58
    • Hattori, R.1    Shimizu, S.2    Majima, Y.3    Shimizu, T.4
  • 19
    • 0016798106 scopus 로고
    • Prostaglandin-induced enhancement of the in vitro anamnetic response
    • Herscowitz H. B., Stylos W. A.: Prostaglandin-induced enhancement of the in vitro anamnetic response. Prostaglandins, 1975;10:87-99
    • (1975) Prostaglandins , vol.10 , pp. 87-99
    • Herscowitz, H.B.1    Stylos, W.A.2
  • 20
    • 57749190751 scopus 로고    scopus 로고
    • Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
    • Hishikari K., Suzuki J., Ogawa M., Isobe K., Takahashi T., Onishi M., Takayama K., Isobe M.: Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. Cardiovasc. Res., 2009;81:123-132
    • (2009) Cardiovasc. Res. , vol.81 , pp. 123-132
    • Hishikari, K.1    Suzuki, J.2    Ogawa, M.3    Isobe, K.4    Takahashi, T.5    Onishi, M.6    Takayama, K.7    Isobe, M.8
  • 21
    • 0038306837 scopus 로고    scopus 로고
    • Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation
    • Hoshino T., Tsutsumi S., Tomisato W., Hwang H. J., Tsuchiya T., Mizushima T.: Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J. Biol. Chem., 2003;278:12752-12758
    • (2003) J. Biol. Chem. , vol.278 , pp. 12752-12758
    • Hoshino, T.1    Tsutsumi, S.2    Tomisato, W.3    Hwang, H.J.4    Tsuchiya, T.5    Mizushima, T.6
  • 24
    • 54249155141 scopus 로고    scopus 로고
    • Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
    • Jain S., Chakraborty G., Raja R., Kale S., Kundu G. C.: Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res., 2008;68:7750-7759
    • (2008) Cancer Res. , vol.68 , pp. 7750-7759
    • Jain, S.1    Chakraborty, G.2    Raja, R.3    Kale, S.4    Kundu, G.C.5
  • 25
    • 78649572788 scopus 로고    scopus 로고
    • Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment
    • Jiang G. L., Im W. B., Donde Y., Wheeler L. A.: Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment. J. Pharmacol. Exp. Ther., 2010;335:546-552
    • (2010) J. Pharmacol. Exp. Ther. , vol.335 , pp. 546-552
    • Jiang, G.L.1    Im, W.B.2    Donde, Y.3    Wheeler, L.A.4
  • 26
    • 33845889285 scopus 로고    scopus 로고
    • The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration
    • Jiang G. L., Nieves A., Im W. B., Old D. W., Dinh D. T., Wheeler L.: The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J. Pharmacol. Exp. Ther., 2007;320:22-28
    • (2007) J. Pharmacol. Exp. Ther. , vol.320 , pp. 22-28
    • Jiang, G.L.1    Nieves, A.2    Im, W.B.3    Old, D.W.4    Dinh, D.T.5    Wheeler, L.6
  • 27
    • 5644234190 scopus 로고    scopus 로고
    • Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide-and CD95-dependent pathway
    • Jones C. P., Paula Neto H. A., Assreuy J., Vargaftig B. B., Gaspar Elsas M. I., Elsas P. X.: Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide-and CD95-dependent pathway. Nitric Oxide, 2004;11:184-193
    • (2004) Nitric Oxide , vol.11 , pp. 184-193
    • Jones, C.P.1    Paula Neto, H.A.2    Assreuy, J.3    Vargaftig, B.B.4    Gaspar Elsas, M.I.5    Elsas, P.X.6
  • 29
    • 27644464641 scopus 로고    scopus 로고
    • IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes
    • Kanda N., Koike S., Watanabe S.: IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J. Allergy Clin. Immunol., 2005;116:1144-1150
    • (2005) J. Allergy Clin. Immunol. , vol.116 , pp. 1144-1150
    • Kanda, N.1    Koike, S.2    Watanabe, S.3
  • 30
    • 22844448233 scopus 로고    scopus 로고
    • Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes
    • Kataoka K., Takikawa Y., Lin S. D., Suzuki K.: Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes. J. Gastroenterol., 2005;40:610-616
    • (2005) J. Gastroenterol. , vol.40 , pp. 610-616
    • Kataoka, K.1    Takikawa, Y.2    Lin, S.D.3    Suzuki, K.4
  • 32
    • 77954071532 scopus 로고    scopus 로고
    • Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function
    • Kim M., Jung M., Hong S. P., Jeon H., Kim M. J., Cho M. Y., Lee S. H., Man M. Q., Elias P. M., Choi E. H.: Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp. Dermatol., 2010;19:501-510
    • (2010) Exp. Dermatol. , vol.19 , pp. 501-510
    • Kim, M.1    Jung, M.2    Hong, S.P.3    Jeon, H.4    Kim, M.J.5    Cho, M.Y.6    Lee, S.H.7    Man, M.Q.8    Elias, P.M.9    Choi, E.H.10
  • 35
    • 4444271426 scopus 로고    scopus 로고
    • Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: Possible involvement of multiple signal transduction and -catenin/T-cell factor
    • Lee E. O., Shin Y. J., Chong Y. H.: Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: possible involvement of multiple signal transduction and -catenin/T-cell factor. J. Neuroimmunol., 2004;155:21-31
    • (2004) J. Neuroimmunol. , vol.155 , pp. 21-31
    • Lee, E.O.1    Shin, Y.J.2    Chong, Y.H.3
  • 36
    • 0036094625 scopus 로고    scopus 로고
    • Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications
    • Levin C., Maibach H. I.: Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am. J. Clin. Dermatol., 2002;3:141-147
    • (2002) Am. J. Clin. Dermatol. , vol.3 , pp. 141-147
    • Levin, C.1    Maibach, H.I.2
  • 37
    • 80555136833 scopus 로고    scopus 로고
    • Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia
    • Liang X., Lin L., Woodling N. S., Wang Q., Anacker C., Pan T., Merchant M., Andreasson K.: Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. J. Clin. Invest., 2011;121:4362-4371
    • (2011) J. Clin. Invest. , vol.121 , pp. 4362-4371
    • Liang, X.1    Lin, L.2    Woodling, N.S.3    Wang, Q.4    Anacker, C.5    Pan, T.6    Merchant, M.7    Andreasson, K.8
  • 38
    • 68349097303 scopus 로고    scopus 로고
    • Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
    • Loong S. L., Hwang J. S., Li H. H., Wee J. T., Yap S. P., Chua M. L., Fong K. W., Tan T. W.: Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). Radiat. Oncol., 2009;4:23
    • (2009) Radiat. Oncol. , vol.4 , pp. 23
    • Loong, S.L.1    Hwang, J.S.2    Li, H.H.3    Wee, J.T.4    Yap, S.P.5    Chua, M.L.6    Fong, K.W.7    Tan, T.W.8
  • 40
    • 0030776485 scopus 로고    scopus 로고
    • Characterization of the prostanoid receptor (s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation
    • Meja K. K., Barnes P. J., Giembycz M. A.: Characterization of the prostanoid receptor (s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation. Br. J. Pharmacol., 1997;122:149-157
    • (1997) Br. J. Pharmacol. , vol.122 , pp. 149-157
    • Meja, K.K.1    Barnes, P.J.2    Giembycz, M.A.3
  • 42
    • 77950646755 scopus 로고    scopus 로고
    • Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial
    • Nakase H., Fujiyama Y., Oshitani N., Oga T., Nonomura K., Matsuoka T., Esaki Y., Murayama T., Teramukai S., Chiba T., Narumiya S.: Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. Infamm. Bowel Dis., 2010;16:731-733
    • (2010) Infamm. Bowel Dis. , vol.16 , pp. 731-733
    • Nakase, H.1    Fujiyama, Y.2    Oshitani, N.3    Oga, T.4    Nonomura, K.5    Matsuoka, T.6    Esaki, Y.7    Murayama, T.8    Teramukai, S.9    Chiba, T.10    Narumiya, S.11
  • 44
    • 0036422957 scopus 로고    scopus 로고
    • Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: Colitis suppression by a selective agonist, ONO-AE1-329
    • Nitta M., Hirata I., Toshina K., Murano M., Maemura K., Hamamoto N., Sasaki S., Yamauchi H., Katsu K.: Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand. J. Immunol., 2002;56:66-75
    • (2002) Scand. J. Immunol. , vol.56 , pp. 66-75
    • Nitta, M.1    Hirata, I.2    Toshina, K.3    Murano, M.4    Maemura, K.5    Hamamoto, N.6    Sasaki, S.7    Yamauchi, H.8    Katsu, K.9
  • 45
    • 33845441547 scopus 로고    scopus 로고
    • Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo
    • Nomi T., Sho M., Akahori T., Kanehiro H., Nakajima Y.: Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. Transplant. Proc., 2006;38:3209-3210
    • (2006) Transplant. Proc. , vol.38 , pp. 3209-3210
    • Nomi, T.1    Sho, M.2    Akahori, T.3    Kanehiro, H.4    Nakajima, Y.5
  • 46
    • 67649610602 scopus 로고    scopus 로고
    • The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation
    • Ogawa M., Suzuki J., Kosuge H., Takayama K., Nagai R., Isobe M.: The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation. Transplantation, 2009;87:1645-1653
    • (2009) Transplantation , vol.87 , pp. 1645-1653
    • Ogawa, M.1    Suzuki, J.2    Kosuge, H.3    Takayama, K.4    Nagai, R.5    Isobe, M.6
  • 48
    • 43949117744 scopus 로고    scopus 로고
    • Effects of the selective EP4 antagonist, CJ-023, 423 on chronic infammation and bone destruction in rat adjuvant-induced arthritis
    • Okumura T., Murata Y., Taniguchi K., Murase A., Nii A.: Effects of the selective EP4 antagonist, CJ-023, 423 on chronic infammation and bone destruction in rat adjuvant-induced arthritis. J. Pharm. Pharmacol., 2008;60:723-730
    • (2008) J. Pharm. Pharmacol. , vol.60 , pp. 723-730
    • Okumura, T.1    Murata, Y.2    Taniguchi, K.3    Murase, A.4    Nii, A.5
  • 49
    • 0036303292 scopus 로고    scopus 로고
    • Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model
    • Omote K., Kawamata T., Nakayama Y., Yamamoto H., Kawamata M., Namiki A.: Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model. Anesthesiology, 2002;97:170-176
    • (2002) Anesthesiology , vol.97 , pp. 170-176
    • Omote, K.1    Kawamata, T.2    Nakayama, Y.3    Yamamoto, H.4    Kawamata, M.5    Namiki, A.6
  • 52
    • 34447135497 scopus 로고    scopus 로고
    • Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo
    • Rao R., Redha R., Macias-Perez I., Su Y., Hao C., Zent R., Breyer M. D., Pozzi A.: Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem., 2007;282:16959-16968
    • (2007) J. Biol. Chem. , vol.282 , pp. 16959-16968
    • Rao, R.1    Redha, R.2    Macias-Perez, I.3    Su, Y.4    Hao, C.5    Zent, R.6    Breyer, M.D.7    Pozzi, A.8
  • 53
    • 0028868941 scopus 로고
    • Cyclosporine-induced renal dysfunction in experimental animals and humans
    • Remuzzi G., Perico N.: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int. Suppl., 1995;52:S70-S74
    • (1995) Kidney Int. Suppl. , vol.52
    • Remuzzi, G.1    Perico, N.2
  • 54
    • 77749343043 scopus 로고    scopus 로고
    • Gastrointestinal and liver adverse effects of drugs used for treating IBD
    • Rogler G.: Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best. Pract. Res. Clin. Gastroenterol., 2010;24, 157-165
    • (2010) Best. Pract. Res. Clin. Gastroenterol. , vol.24 , pp. 157-165
    • Rogler, G.1
  • 56
    • 2442537090 scopus 로고    scopus 로고
    • A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2
    • Sasaoka R., Terai H., Toyoda H., Imai Y., Sugama R., Takaoka K.: A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun., 2004;318:704-709
    • (2004) Biochem. Biophys. Res. Commun. , vol.318 , pp. 704-709
    • Sasaoka, R.1    Terai, H.2    Toyoda, H.3    Imai, Y.4    Sugama, R.5    Takaoka, K.6
  • 57
    • 77953638394 scopus 로고    scopus 로고
    • The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity
    • Shi J., Johansson J., Woodling N. S., Wang Q., Montine T. J., Andreasson K.: The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol., 2010;184:7207-7218
    • (2010) J. Immunol. , vol.184 , pp. 7207-7218
    • Shi, J.1    Johansson, J.2    Woodling, N.S.3    Wang, Q.4    Montine, T.J.5    Andreasson, K.6
  • 58
    • 77954652338 scopus 로고    scopus 로고
    • PGE2 is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation
    • Starner R. J., McClelland L., Abdel-Malek Z., Fricke A., Scott G.: PGE2 is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation. Exp. Dermatol., 2010;19:682-684
    • (2010) Exp. Dermatol. , vol.19 , pp. 682-684
    • Starner, R.J.1    McClelland, L.2    Abdel-Malek, Z.3    Fricke, A.4    Scott, G.5
  • 60
    • 33745622119 scopus 로고    scopus 로고
    • COX-1 inhibition enhances scratching behavior in NC/Nga mice with atopic dermatitis
    • Sugimoto M., Arai I., Futaki N., Hashimoto Y., Honma Y., Nakaike S.: COX-1 inhibition enhances scratching behavior in NC/Nga mice with atopic dermatitis. Exp. Dermatol., 2006;15:582-588
    • (2006) Exp. Dermatol. , vol.15 , pp. 582-588
    • Sugimoto, M.1    Arai, I.2    Futaki, N.3    Hashimoto, Y.4    Honma, Y.5    Nakaike, S.6
  • 61
    • 38149119628 scopus 로고    scopus 로고
    • Antiinflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway
    • Sur R., Babad J. M., Garay M., Liebel F. T., Southall M. D.: Antiinflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway. J. Invest. Dermatol., 2008;128:336-344
    • (2008) J. Invest. Dermatol. , vol.128 , pp. 336-344
    • Sur, R.1    Babad, J.M.2    Garay, M.3    Liebel, F.T.4    Southall, M.D.5
  • 65
    • 77951586516 scopus 로고    scopus 로고
    • Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors
    • Takeuchi K., Tanigami M., Amagase K., Ochi A., Okuda S., Hatazawa R.: Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors. J. Gastroenterol. Hepatol., 2010;25(Suppl.1):S67-S74
    • (2010) J. Gastroenterol. Hepatol. , vol.25 , Issue.SUPPL. 1
    • Takeuchi, K.1    Tanigami, M.2    Amagase, K.3    Ochi, A.4    Okuda, S.5    Hatazawa, R.6
  • 66
    • 33846427739 scopus 로고    scopus 로고
    • Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells
    • Takita M., Inada M., Maruyama T., Miyaura C.: Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. FEBS Lett., 2007;581:565-571
    • (2007) FEBS Lett. , vol.581 , pp. 565-571
    • Takita, M.1    Inada, M.2    Maruyama, T.3    Miyaura, C.4
  • 67
    • 84857053651 scopus 로고    scopus 로고
    • Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases
    • Tang E. H., Libby P., Vanhoutte P. M., Xu A.: Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J. Cardiovasc. Pharmacol., 2012;59:116-123
    • (2012) J. Cardiovasc. Pharmacol. , vol.59 , pp. 116-123
    • Tang, E.H.1    Libby, P.2    Vanhoutte, P.M.3    Xu, A.4
  • 68
    • 0034737777 scopus 로고    scopus 로고
    • Biphasic actions of prostaglandin E (2) on the renal afferent arteriole: Role of EP (3) and EP (4) receptors
    • Tang L., Loutzenhiser K., Loutzenhiser R.: Biphasic actions of prostaglandin E (2) on the renal afferent arteriole: role of EP (3) and EP (4) receptors. Circ. Res., 2000;86:663-670
    • (2000) Circ. Res. , vol.86 , pp. 663-670
    • Tang, L.1    Loutzenhiser, K.2    Loutzenhiser, R.3
  • 70
    • 0036319489 scopus 로고    scopus 로고
    • Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro
    • Weinreb M., Kelner A., Keila S.: Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro. J. Endocrinol., 2002;174:127-135
    • (2002) J. Endocrinol. , vol.174 , pp. 127-135
    • Weinreb, M.1    Kelner, A.2    Keila, S.3
  • 71
    • 33747827859 scopus 로고    scopus 로고
    • Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity
    • Weinreb M., Shamir D., Machwate M., Rodan G. A., Harada S., Keila S.: Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Prostaglandins Leukot. Essent. Fatty Acids, 2006;75:81-90
    • (2006) Prostaglandins Leukot. Essent. Fatty Acids , vol.75 , pp. 81-90
    • Weinreb, M.1    Shamir, D.2    Machwate, M.3    Rodan, G.A.4    Harada, S.5    Keila, S.6
  • 72
    • 27744477634 scopus 로고    scopus 로고
    • Prostanoids as friends, not foes: Further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats
    • Whitehouse M. W.: Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats. Inflammopharmacology, 2005;12:481-492
    • (2005) Inflammopharmacology , vol.12 , pp. 481-492
    • Whitehouse, M.W.1
  • 73
    • 51549117698 scopus 로고    scopus 로고
    • Prostacyclin (epoprostenol) induces headache in healthy subjects
    • Wienecke T., Olesen J., Oturai P. S., Ashina M.: Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain, 2008;139:106-116
    • (2008) Pain , vol.139 , pp. 106-116
    • Wienecke, T.1    Olesen, J.2    Oturai, P.S.3    Ashina, M.4
  • 74
    • 63849165405 scopus 로고    scopus 로고
    • Prostaglandin E2 (PGE2) induces headache in healthy subjects
    • Wienecke T., Olesen J., Oturai P. S., Ashina M.: Prostaglandin E2 (PGE2) induces headache in healthy subjects. Cephalalgia, 2009;29:509-519
    • (2009) Cephalalgia , vol.29 , pp. 509-519
    • Wienecke, T.1    Olesen, J.2    Oturai, P.S.3    Ashina, M.4
  • 76
    • 0034638635 scopus 로고    scopus 로고
    • Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils
    • Yamane H., Sugimoto Y., Tanaka S., Ichikawa A.: Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem. Biophys. Res. Commun., 2000;278:224-228
    • (2000) Biochem. Biophys. Res. Commun. , vol.278 , pp. 224-228
    • Yamane, H.1    Sugimoto, Y.2    Tanaka, S.3    Ichikawa, A.4
  • 78
    • 0017092509 scopus 로고
    • The regulation of the immune response to T-independent antigens by prostaglandins and B cells
    • Zimecki M., Webb D. R.: The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J. Immunol., 1976;117:2158-2164
    • (1976) J. Immunol. , vol.117 , pp. 2158-2164
    • Zimecki, M.1    Webb, D.R.2
  • 79
    • 0019143985 scopus 로고
    • The regulation of the immune response to polyvinylpyrollidone: Antigen induced changes in prostaglandin and cyclic nucleotide levels
    • Zimecki M., Webb D. R., Rogers T. J.: The regulation of the immune response to polyvinylpyrollidone: antigen induced changes in prostaglandin and cyclic nucleotide levels. Arch. Immunol. Ther. Exp., 1980;28:179-197
    • (1980) Arch. Immunol. Ther. Exp. , vol.28 , pp. 179-197
    • Zimecki, M.1    Webb, D.R.2    Rogers, T.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.